MND-SMART Trial update

male participant talking to MND-SMART research nurse

April 2022:  Stage 1 analysis of memantine and trazodone.

An independent trial committee for the MND-SMART trial recently reviewed stage 1 data for the drugs that are currently being tested in MND-SMART.

The outcome was that we should continue testing both memantine and trazodone, collecting data to determine whether either drug slows down the progression of MND.

In this video the MND-SMART trial management team provide an update on the outcomes and what this means for our participants.

This article was published on: Tuesday, April 05, 2022
×